LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,588,611 | +6.3% | 83,201 | +9.3% | 0.26% | +8.5% |
| Q2 2023 | $5,255,185 | +50.2% | 76,129 | +4.9% | 0.24% | +33.3% |
| Q1 2023 | $3,498,554 | -5.2% | 72,554 | -1.8% | 0.18% | -31.9% |
| Q4 2022 | $3,689,487 | -42.6% | 73,908 | -53.1% | 0.26% | -49.9% |
| Q3 2022 | $6,431,000 | -24.8% | 157,629 | +1.4% | 0.52% | -24.3% |
| Q2 2022 | $8,553,000 | +4.2% | 155,500 | -31.2% | 0.69% | +68.6% |
| Q1 2022 | $8,208,000 | -28.0% | 225,880 | -7.7% | 0.41% | -25.2% |
| Q4 2021 | $11,407,000 | +1.8% | 244,733 | +10.5% | 0.54% | -45.1% |
| Q3 2021 | $11,202,000 | +23.8% | 221,562 | +0.5% | 0.99% | +26.7% |
| Q2 2021 | $9,050,000 | +80.7% | 220,470 | +27.8% | 0.78% | +63.6% |
| Q1 2021 | $5,007,000 | -39.6% | 172,546 | -41.3% | 0.48% | -44.8% |
| Q4 2020 | $8,283,000 | -11.4% | 294,140 | -2.9% | 0.87% | -24.5% |
| Q3 2020 | $9,349,000 | -30.4% | 302,860 | -4.0% | 1.15% | -35.8% |
| Q2 2020 | $13,428,000 | – | 315,510 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |